Interestingly, the signalling pathways regulated by ARID1A, FRAT2, and MAZ have at least one target in common, namely, c-MYC [48–50], which is known to be overexpressed in mouse HCC [51]. The gene discussed is MAZ; the disease is hepatocellular carcinoma.